TYP 0.00% 1.8¢ tryptamine therapeutics limited

Ann: Independent Plexaris and Cevaris testing, page-3

  1. 7,588 Posts.
    lightbulb Created with Sketch. 865
    “The testing showed that both Plexaris and Cevaris had different and distinct activities to
    comparison drugs. This confirms our belief that exosomes are a distinct and potentially
    new class of medicine, different from existing medicines,” he adds. “Importantly, neither
    was shown to be cytotoxic, and neither caused antiproliferative effects at the
    concentrations tested.”
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
0.000(0.00%)
Mkt cap ! $19.60M
Open High Low Value Volume
1.8¢ 1.8¢ 1.8¢ $12.05K 669.5K

Buyers (Bids)

No. Vol. Price($)
1 648601 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 525000 2
View Market Depth
Last trade - 13.54pm 27/09/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.